Antitrust lawsuit filed against Mylan, other generics manufacturers

Mylan NV and six other pharmaceutical companies are the targets of an antitrust lawsuit alleging that it illegally increased drug prices, including beefing up the price tags on doxycycline and digoxin. The plaintiff is the Rochester Drug Cooperative, a wholesale drug company based in Rochester, New York. The two drugs referenced in the suit are doxycycline, an antibiotic, and digoxin, a cardiac ailment treatment, which "exemplify this issue," says the suit. Both drugs recently experienced a surge…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news